| Category | Parameter | Wt. | Score | Notes |
|---|---|---|---|---|
| Quality | Business Quality | 10.00% | 7.5 | ๐ Infosys FY26 Release, Apr 2026 $14.9B in large-deal TCV for FY26 shows continued strong client trust, even as overall revenue growth remained modest amid macro headwinds. |
| Quality | Management Quality | 10.00% | 8 | ๐ Sharekhan (Mirae Asset), Jan 2026 Upgraded FY26 guidance twice during the year (0-3% โ 1-3% โ 3-3.5%) as execution outperformed initial caution โ credible, not over-promising. |
| Quality | Growth Visibility | 10.00% | 8 | ๐ Sharekhan, Jan 2026 Q3 FY26 TCV surged 92% YoY to $4.8B including a $1.6B NHS mega deal; 9M TCV of $11.7B already exceeded full-year FY25 TCV. |
| Quality | Moat | 10.00% | 7 | ๐ Sharekhan, Jan 2026 Infosys Topaz (AI platform) is increasingly positioned as a client differentiator, though the IT services moat overall is narrower than in banking/consumer sectors. |
| Quality | Capital Allocation | 6.67% | 8 | ๐ Infosys FY26 Release, 2026 Completed its largest-ever buyback (โน18,000 Cr) alongside continued dividend payouts โ consistent, shareholder-friendly capital return. |
| Quality | Balance Sheet | 6.67% | 9 | ๐ Infosys FY26 Release, 2026 Free cash flow consistently above 100-130% of net profit across FY26 quarters โ an exceptionally clean, asset-light balance sheet. |
| Quality | Risk Profile | 6.66% | 6.5 | ๐ Sharekhan, Jan 2026 Manufacturing and retail sectors showed macro headwinds through FY26; margins absorbed wage hikes and currency pressure without much cushion. |
| Price | Valuation | 13.33% | 6.5 | ๐ Sharekhan, Jan 2026 Trades at ~20.6x FY27E and 19.2x FY28E PE โ a reasonable multiple given the record deal-win momentum and guidance upgrades through FY26. |
| Price | FCF Yield | 13.33% | 8 | ๐ Infosys FY26 Release, 2026 Adjusted FCF consistently at 100-130% of net profit is an outstanding cash-conversion profile, supporting a genuinely healthy FCF yield. |
| Price | Reverse DCF | 13.34% | 6.5 | ๐ Sharekhan, Jan 2026 Current valuation assumes FY27 acceleration on the back of record TCV converting to revenue โ a reasonable bet given the demonstrated deal pipeline. |
| Quality 60.00% / Price 40.00% | 7.42 | |||
| Trigger | Action |
|---|---|
| TCV-to-revenue conversion shows through in accelerating FY27 growth as guided | Add |
| Manufacturing/retail vertical headwinds ease for 2+ consecutive quarters | Review |
| Metric | Current | Historical | Source |
|---|---|---|---|
| PE (FY27E/FY28E) | 20.6x / 19.2x | โ | Sharekhan, Jan 2026 |
| TCV (FY26) | $14.9 Bn | โ | Infosys FY26 Release, 2026 |
| Operating Margin | 20-22% (guided) | โ | Infosys FY26 Release, 2026 |
| Revenue Growth (FY26 CC) | +3.1% | Upgraded from 0-3% guidance | Infosys FY26 Release, 2026 |
| Competitor | Segment | Threat |
|---|---|---|
| TCS | IT Services | High |
| HCL Technologies / Wipro | IT Services | Medium |
| Accenture / Cognizant (global) | IT Services / Consulting | Medium |